Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

Detalles Bibliográficos
Autores principales: Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671451/
https://www.ncbi.nlm.nih.gov/pubmed/36395352
http://dx.doi.org/10.18632/oncotarget.28312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671451/
https://www.ncbi.nlm.nih.gov/pubmed/36395352
http://dx.doi.org/10.18632/oncotarget.28312

Ejemplares similares